Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

IRENE TANEDO HERNAEZ

Podiatric Medicine & Surgery Service Providers Podiatrist

NPI
1184624892
CMS profile
1250629
Location
SUGAR LAND, TX

General Payments · PY2018–2024

$10,085.86

  • Reported across 257 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,458.75

33 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,458.75 33

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Paratek Pharmaceuticals, Inc. $347.88 16
RedDress USA, Inc. $224.93 1
Kerecis Limited $185.66 1
Averitas Pharma Inc. $159.00 4
Amgen Inc. $150.35 2
ABBVIE INC. $145.93 2
MIMEDX Group, Inc. $131.60 2
TREACE MEDICAL CONCEPTS, INC. $55.65 2
Smith & Nephew, Inc. $39.06 2
BIOTISSUE HOLDINGS INC. $18.69 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,070.50 57
PY2019 $3,009.57 66
PY2020 $208.01 11
PY2021 $2,330.24 23
PY2022 $1,278.36 37
PY2023 $730.43 30
PY2024 $1,458.75 33

Payment records · PY2024 (33)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $125.00 02/22/2024 Food and Beverage Undisputed 01/23/2026 1103909358 CMS
ABBVIE INC. $20.93 03/13/2024 Food and Beverage Undisputed 01/23/2026 1103909360 CMS
Amgen Inc. $25.31 02/03/2024 Food and Beverage Undisputed 01/23/2026 1111598338 CMS
Amgen Inc. $125.04 03/21/2024 Food and Beverage Undisputed 01/23/2026 1111598340 CMS
Averitas Pharma Inc. $68.51 04/18/2024 Food and Beverage Undisputed 01/23/2026 1133429483 CMS
Averitas Pharma Inc. $46.52 06/07/2024 Food and Beverage Undisputed 01/23/2026 1133429488 CMS
Averitas Pharma Inc. $21.69 07/05/2024 Food and Beverage Undisputed 01/23/2026 1133429492 CMS
Averitas Pharma Inc. $22.28 12/02/2024 Food and Beverage Undisputed 01/23/2026 1133429495 CMS
BIOTISSUE HOLDINGS INC. $18.69 05/27/2024 Food and Beverage Undisputed 01/23/2026 1148774523 CMS
Kerecis Limited $185.66 08/21/2024 Food and Beverage Undisputed 01/23/2026 1120117804 CMS
MIMEDX Group, Inc. $3.74 06/12/2024 Food and Beverage Undisputed 01/23/2026 1140260873 CMS
MIMEDX Group, Inc. $127.86 06/12/2024 Food and Beverage Undisputed 01/23/2026 1140260875 CMS
Paratek Pharmaceuticals, Inc. $5.54 01/25/2024 Food and Beverage Undisputed 01/23/2026 1113903397 CMS
Paratek Pharmaceuticals, Inc. $17.46 02/16/2024 Food and Beverage Undisputed 01/23/2026 1113903399 CMS
Paratek Pharmaceuticals, Inc. $99.40 02/27/2024 Food and Beverage Undisputed 01/23/2026 1113903401 CMS
Paratek Pharmaceuticals, Inc. $6.06 03/08/2024 Food and Beverage Undisputed 01/23/2026 1113903403 CMS
Paratek Pharmaceuticals, Inc. $21.21 03/22/2024 Food and Beverage Undisputed 01/23/2026 1113903405 CMS
Paratek Pharmaceuticals, Inc. $4.20 04/09/2024 Food and Beverage Undisputed 01/23/2026 1113903407 CMS
Paratek Pharmaceuticals, Inc. $6.23 05/06/2024 Food and Beverage Undisputed 01/23/2026 1113903409 CMS
Paratek Pharmaceuticals, Inc. $24.88 05/22/2024 Food and Beverage Undisputed 01/23/2026 1113903411 CMS
Paratek Pharmaceuticals, Inc. $19.88 05/28/2024 Food and Beverage Undisputed 01/23/2026 1113903413 CMS
Paratek Pharmaceuticals, Inc. $24.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 1113903415 CMS
Paratek Pharmaceuticals, Inc. $8.58 07/29/2024 Food and Beverage Undisputed 01/23/2026 1113903417 CMS
Paratek Pharmaceuticals, Inc. $24.05 08/16/2024 Food and Beverage Undisputed 01/23/2026 1113903419 CMS
Paratek Pharmaceuticals, Inc. $22.98 09/20/2024 Food and Beverage Undisputed 01/23/2026 1113903421 CMS
Paratek Pharmaceuticals, Inc. $24.52 10/19/2024 Food and Beverage Undisputed 01/23/2026 1113903423 CMS
Paratek Pharmaceuticals, Inc. $24.96 11/23/2024 Food and Beverage Undisputed 01/23/2026 1113903425 CMS
Paratek Pharmaceuticals, Inc. $13.00 12/16/2024 Food and Beverage Undisputed 01/23/2026 1113903427 CMS
RedDress USA, Inc. $224.93 07/31/2024 Food and Beverage Undisputed 01/23/2026 1098253741 CMS
Smith+Nephew, Inc. $13.61 03/08/2024 Food and Beverage Undisputed 01/23/2026 1149506930 CMS
Smith+Nephew, Inc. $25.45 06/21/2024 Food and Beverage Undisputed 01/23/2026 1149506932 CMS
TREACE MEDICAL CONCEPTS, INC. $36.24 02/07/2024 Food and Beverage Undisputed 01/23/2026 1151446092 CMS
TREACE MEDICAL CONCEPTS, INC. $19.41 05/07/2024 Food and Beverage Undisputed 01/23/2026 1151435397 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.